Trident Lifeline Peer Comparison

BSE: 543616

₹405.95

₹-4.05 (-0.99%)

As on 29-Sep-2026IST

Market cap

₹485 Cr

Revenue (TTM)

₹87 Cr

P/E Ratio

25.5

P/B Ratio

4.9

Div. Yield

0 %

Edit

	Trident Lifeline	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	485	20,853	20,665	17,907	16,905
Revenue (₹ Cr)	87	2,287	1,682	2,570	3,230
Net Profit (₹ Cr)	10.49	678.07	273.51	735.15	666.92
Net Margin (%)	11.02	28.10	16.19	26.88	20.60
RoE (%)	18.78	19.73	11.15	19.16	18.75
Price to Earnings	25.49	31.34	69.51	24.36	26.25
Price-To-Book	4.93	5.68	7.69	4.06	4.19

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Trident Lifeline	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Operating Revenue	86.96	1,937.47	1,286.43	2,281.35	2,893.64
Total Income	95.20	2,033.90	1,322.88	2,453.60	2,912.00
Total Expenditure	71.95	1,290.54	980.18	1,541.03	1,876.44
EBITDA	15.02	646.93	306.25	740.32	1,017.20
Depreciation	5.49	65.96	112.99	60.79	315.46
EBIT	9.52	580.97	193.26	679.53	701.74
Interest	4.14	0.61	75.53	8.50	231.29
Other Income	8.23	96.43	36.45	172.25	18.36
Exceptional Items	--	--	-30.58	172.81	--
Profit before Tax	13.61	676.78	122.33	1,016.09	488.87
Provision for Tax	3.12	135.69	44.04	248.49	114.20
Profit after Tax	10.49	541.09	78.29	767.60	374.67

Liabilities (₹ Cr)

	Trident Lifeline	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Shareholder's Funds	64.46	2,850.49	2,362.70	4,217.41	2,854.36
Minority Interest	5.19	35.90	1.04	--	417.40
Non-Current Liabilities	30.40	13.24	259.78	54.89	2,100.97
Current Liabilities	55.20	305.99	674.19	569.51	1,492.79
Total Liabilities	157.20	3,207.85	3,310.68	4,911.11	6,865.52

Assets (₹ Cr)

	Trident Lifeline	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Non-Current Assets	60.60	1,071.67	2,313.20	1,328.96	5,531.13
Current Assets	92.02	2,133.95	984.51	3,512.85	1,334.39
Total Assets	157.20	3,207.85	3,310.68	4,911.11	6,865.52
Total Debt*	54.03	0.55	586.37	2.50	2,421.66
Net Current Assets	36.82	1,827.96	310.32	2,943.34	-158.40
Contingent Liabilities	17.00	0.64	76.22	363.79	51.96

Cashflow (₹ Cr)

	Trident Lifeline	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Cash From Operating Activities	-10.24	432.37	132.27	659.75	1,065.01
Cash Flow from Investing Activities	-13.82	-334.73	-199.13	-71.34	-79.97
Cash from Financing Activities	19.76	-38.32	62.65	-205.34	-881.32
Net Cash Inflow / Outflow	-4.31	59.32	-4.21	383.07	103.72

Ratios

Profitability Ratios

	Trident Lifeline	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
ROCE (%)	19.17	26.22	6.95	26.21	13.59
ROE (%)	18.78	21.72	3.75	19.65	13.81
ROA (%)	8.64	18.37	2.45	17.03	5.48
EBIT Margin (%)	26.73	38.37	26.64	40.00	35.79
Net Margin (%)	11.02	26.60	5.92	31.28	12.87
Cash Profit Margin (%)	18.38	31.33	14.87	34.70	23.21

Growth Ratios

	Trident Lifeline	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Revenue Growth (%)	94.86	14.37	11.71	4.02	44.02
EBIT Growth (%)	125.42	20.21	35.64	11.86	48.22
Net Profit Growth (%)	76.69	17.27	145.00	39.23	-5.65
EPS Growth (%)	85.19	17.25	118.00	39.23	-10.39
Book Value Growth (%)	23.80	23.77	30.63	17.30	10.19

Valuation Ratios

	Trident Lifeline	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Price / Earnings	25.16	28.38	41.41	23.86	54.83
Price / Book Value	4.78	5.52	2.74	4.34	6.78
Dividend Yield (%)	0.00	0.30	0.15	4.12	0.52
EV/EBITDA	14.93	19.78	20.55	17.01	20.75
Market Cap (₹ Cr)	295.53	15,219.80	6,484.12	18,318.10	19,292.77

Solvency Ratios

	Trident Lifeline	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debt to Equity	0.87	0.00	0.25	0.00	0.85
Short term debt to equity ratio	0.26	0.00	0.13	0.00	0.14
Current Ratio	1.67	6.97	1.46	6.17	0.89
Quick Ratio	1.16	5.88	0.94	5.33	0.67
Interest Coverage	4.29	1,110.48	2.62	120.54	3.11

Operating Efficiency Ratios

	Trident Lifeline	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debtors to sales (%)	31.83	32.65	34.26	8.46	15.85
Asset Turnover	0.72	0.66	0.40	0.53	0.43
Receivable days	86.30	110.70	118.15	29.10	54.06
Inventory Days	85.68	65.86	98.29	69.53	32.16
Payable days	110.89	105.88	128.16	76.77	140.91
Cash Conversion Cycle	61.09	70.68	88.28	21.86	-54.69